Amniotic Membrane Application in the Management of Ocular Surface Diseases.
Wydanie 1/2021
str. 37 – 39
Autorzy: Monika Sarnat-Kucharczyk1,2, Ewa Mrukwa-Kominek1,2
1 Klinika Okulistyki Katedry Okulistyki Wydział Nauk Medycznych w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach
Kierownik: prof. dr hab. n. med. Ewa Mrukwa-Kominek
2 Oddział Okulistyki Dorosłych Uniwersyteckiego Centrum Klinicznego im. prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego w Katowicach
Kierownik: prof. dr hab. n. med. Ewa Mrukwa-Kominek
Summary:
Amniotic membrane is a rich source of biologically active factors and as such, has an essential role in promoting healing and acting as an effective material for wound dressing.
Amniotic membrane exhibits anti-fibrotic, anti-inflammatory, anti-angiogenic, anti-microbial features and supports epithelialization. In ophthalmology amniotic membrane has been widely in various ocular surface reconstruction in the management of diseases such as limbal cell deficiency, post-inflammatory and post-trauma conditions. Additionally, may be used in glaucoma surgery, in eye tissue malathions, in treating corneal and scleral perforations.